GSK Plc’s older respiratory medicines showed lackluster sales in the first quarter, leaving HIV and cancer drugs to drive ...
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...
Emma Walmsley has served as CEO of GlaxoSmithKline since 2017. From the Philadelphia Business Journal. GSK is making a change at the top. The London-based Big Pharma company, which has major ...
GSK CEO Emma Walmsley has said she finds it “obnoxious” when company leaders complain about how hard their jobs are. Speaking at the Fortune Most Powerful Women (MPW) Summit, Walmsley called being a ...
When it comes to GSK’s new dealmaking strategy of trying to outdo established blockbusters, CEO Luke Miels has told Fierce that oncology may offer the most tempting targets. | When it comes to GSK’s ...
Diageo (DEO) has considered a multitude of internal and external candidates, including Emma Walmsley, outgoing CEO of GSK (GSK), for the company’s leadership role, The Financial Times reported on ...
GSK stock declined 3% despite beating Q1 earnings estimates. Analysts note legal provisions contributed half the beat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results